2013.03.05,我院吴缅/梅一德教授研究组在《自然-通讯》(Nature Communications 2013, 4: 1551,DOI 10.1038/ncomms2533)上在线发表文章

时间:2021-04-12 21:27:01学院:生命科学学院学校:中国科学技术大学
2013.03.05,我院吴缅/梅一德教授研究组在《自然-通讯》(Nature Communications 2013, 4: 1551,DOI 10.1038/ncomms2533)杂志上在线发表论文 “Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase”。

Wang X, Zha M, Zhao X, Jiang P, Du W, Tam AY, Mei Y, Wu M

Abstract

The tumour suppressor alternative reading frame (ARF) is one of the most frequently mutated proteins in human cancer. It has been well established that ARF is able to stabilize and activate p53 by directly inhibiting Mdm2. ARF-mediated p53 activation in response to oncogenic stress is thought to be an important determinant of protection against cancer. However, little is known regarding the control of ARF in cells. Here, we show that Siva1 is a specific E3 ubiquitin ligase of ARF. Siva1 physically interacts with ARF both in vitro and in vivo. Through direct interaction, Siva1 promotes the ubiquitination and degradation of ARF, which in turn affects the stability of p53. Functionally, Siva1 regulates cell cycle progression and cell proliferation in an ARF/p53-dependent manner. Our results uncover a novel regulatory mechanism for the control of ARF stability, thereby revealing an important function of Siva1 in the regulation of the ARF-Mdm2-p53 pathway.

 



版权与免责声明:本网页的内容由收集互联网上公开发布的信息整理获得。目的在于传递信息及分享,并不意味着赞同其观点或证实其真实性,也不构成其他建议。仅提供交流平台,不为其版权负责。如涉及侵权,请联系我们及时修改或删除。邮箱:sales@allpeptide.com

返回首页 浙公网安备 33010602009704号;浙ICP备18001318号